The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
about
Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamineEbastine in allergic rhinitis and chronic idiopathic urticariaA comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adultsEbastine in chronic urticaria: A double-blind placebo-controlled studyApplication of a rapid and selective method for the simultaneous determination of carebastine and pseudoephedrine in human plasma by liquid chromatography-electrospray mass spectrometry for bioequivalence study in Korean subjects.Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute UrticariaSmall molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastineClinical utility and patient adherence with ebastine for allergic rhinitis.Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentrationCimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.Duration of the antihistaminic effect after discontinuation of ebastine.Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects.
P2860
Q24564984-321F433D-15EB-404E-A1B2-2CF9D73E7AD3Q28301769-DD2F2406-46A4-4301-B6BE-97CE23A283C9Q28305881-6098A6C1-D174-4964-940D-8EDE3755DE54Q30049106-A0DD726C-22DC-486F-A4F1-79C38D3285BEQ30976999-51C43A5A-3B81-4DA8-80C2-F857E4EB1774Q33666953-E7BEAC3E-7011-42D8-A695-454934A63315Q33985125-89FDA6FF-5EEA-4189-84FC-DF3C8B99B706Q34403712-C3C2DD7B-889A-417C-90CB-499D7B901C89Q34413618-2C18D205-CD37-42B0-8E9D-8686D73C4A72Q34514895-E04C6EF3-33C7-4168-A437-67063A5FB3B3Q34579726-75B44E5B-9FB0-4FC7-8CFD-DA58198B3C0EQ34668629-B249A267-5D1F-4EFA-BA03-40238B445DFEQ42250461-F237CEA6-05BF-440A-ABA2-CF929C7737B8Q42284366-B0C9B548-3516-458D-BCB4-03E9DBB59BB3Q43224675-20160A77-A424-455F-9BA6-6F4305833F63Q43650414-33A1F33D-1CC6-43BC-B775-F483E0E67BEDQ45148117-18E2F8FB-0EB8-4582-B147-B568A8B958D0Q50795746-7D35AAB2-14FD-4841-9969-E465F1158029
P2860
The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@ast
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@en
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@nl
type
label
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@ast
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@en
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@nl
prefLabel
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@ast
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@en
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@nl
P2093
P2860
P1476
The pharmacokinetics, antihist ...... ebastine in healthy subjects.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1988.TB05288.X
P407
P577
1988-11-01T00:00:00Z